(Q52068855)

21 April 2018

title

The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial. (English)

1 reference

21 April 2018

1 reference

1 reference

head and neck carcinoma

1 reference

8

Lenarz T

1 reference

21 April 2018

author name string

Steuer-Vogt MK

1

1 reference

21 April 2018

Bonkowsky V

2

1 reference

21 April 2018

Ambrosch P

3

1 reference

21 April 2018

Scholz M

4

1 reference

21 April 2018

Neiss A

5

1 reference

21 April 2018

Strutz J

6

1 reference

21 April 2018

Hennig M

7

1 reference

21 April 2018

Arnold W

9

1 reference

21 April 2018

publication date

1 January 2001

1 reference

21 April 2018

European Journal of Cancer

published in

1 reference

21 April 2018

volume

37

1 reference

21 April 2018

issue

1

1 reference

21 April 2018

page(s)

23-31

1 reference

21 April 2018

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

The prevalence of complementary/alternative medicine in cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

Prevalence of complementary/alternative medicine for children: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

Alternative therapies used by women with breast cancer in four ethnic populations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

The use of unproven methods of treatment by cancer patients. Frequency, expectations and cost

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

[Use of alternative medicine in oncology patients]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

Mistletoe treatment for cancer review of controlled trials in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

Mistletoe lectin I-induced effects on human cytotoxic lymphocytes. I. Synergism with IL-2 in the induction of enhanced LAK cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

The immunopharmacology of head and neck cancer: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

In vitro T-lymphocyte function in head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

Peripheral blood mononuclear cell (PBMC) responsiveness in patients with head and neck cancer in relation to tumour stage and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

A comparison of sample size methods for the logrank statistic

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

Alternative medicine--the risks of untested and unregulated remedies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

Current options in management of head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

Prognostic value of histologic findings in neck dissections for squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

Distant metastases from head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

Synchronous and metachronous head and neck carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. EUROCARE Working Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

The National Cancer Data Base report on cancer of the head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

1 reference

7 January 2021

Inability of galactoside-specific mistletoe lectin to inhibit N-methyl-N-nitrosourea-induced tumor development in the urinary bladder of rats and to mediate a local cellular immune response after long-term administration

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune re

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

[Development of lymphocyte subsets in tumor patients after subcutaneous administration of mistletoe extracts]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900360-9

7 January 2021

10.1016/S0959-8049(00)00360-9

Identifiers

DOI

1 reference

21 April 2018

1 reference

21 April 2018